Since that discovery, more than 31 distinct fusion partner genes of NUP98 have been identified in various hematological malignancies, including T-cell acute lymphoblastic leukemia 18, chronic myeloid leukemia (CML) 19, and AML 20. This evidence concerns the gene NUP98 and chronic myelogenous leukemia, BCR-ABL1 positive.